Nozomu Hibi
Nozomu Hibi publishes mostly in Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Antioxidant Activity and Oxidative Stress.
- World rank
- #5,652,749 of 7,710,434 ranked researchers
- Rank in Japan
- #197,753 of 383,136
- Works
- 63
- Citations
- 1.1k
- Citations per work
- 18.0
What does Nozomu Hibi research?
Nozomu Hibi's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Medicine (13%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2945.3%
- Life Sciences2642.0%
- Health Sciences812.7%
- Medicine812.7%
- 1Molecular Biology24% of their works
- 2Immunology8% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Oncology6% of their works
- 5Genetics6% of their works
- 6Biotechnology5% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Antioxidant Activity and Oxidative Stress
- Animal Genetics and Reproduction
- Toxin Mechanisms and Immunotoxins
- Enzyme Production and Characterization
- Viral Infectious Diseases and Gene Expression in Insects
- Atherosclerosis and Cardiovascular Diseases
Which keywords describe Nozomu Hibi's research?
The keywords of their largest research topics: Glycosylation, Atherosclerosis, Inflammation, Biopharmaceutical Production, Fc Receptors, Therapeutic Antibodies, Cancer and Glycans.
- Recombinant Protein
- Microbial Enzymes
- Immune Response
- Transgenic Animals
- Immunotoxin
- Oxidative Stress
- Glycans
- Therapeutic Antibodies
- Biopharmaceutical Production
- Atherosclerosis
- Glycosylation
- Inflammation
- Fc Receptors
- Cancer
- Antioxidants
- Genetic Modification
- Ricin Poisoning
- Biotechnological Applications
- Mammalian Cells
- Oxidized LDL
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Glycosylation213 topics
- Atherosclerosis102 topics
- Inflammation102 topics
- Biopharmaceutical Production92 topics
- Fc Receptors91 topic
- Therapeutic Antibodies91 topic
- Cancer81 topic
- Glycans81 topic
- Antioxidants61 topic
- Oxidative Stress61 topic
- Genetic Modification51 topic
- Immunotoxin51 topic
- Ricin Poisoning51 topic
- Transgenic Animals51 topic
- Biotechnological Applications41 topic
- Immune Response41 topic
- Mammalian Cells41 topic
- Microbial Enzymes41 topic
- Oxidized LDL41 topic
- Recombinant Protein41 topic
Where does Nozomu Hibi work?
Nozomu Hibi's main affiliation in the publication record is Hokkaido University, Japan.
How many publications and citations does Nozomu Hibi have?
OpenAlex counts 63 works and 1,135 citations for Nozomu Hibi, an h-index of 16, ranking #5,652,749 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nozomu Hibi. Posts are plain text and can be reported.